Drug & supplement interaction

Fucus Vesiculosus + Erdafitinib

Erdafitinib brand name: Balversa.

Minor Interaction
The bottom line Minor

Erdafitinib falls into 2 drug categories that Fucus Vesiculosus can interact with; the most serious is rated minor. Theoretically, concomitant use of Fucus vesiculosus with CYP2C9 substrates might increase the risk for adverse effects.

Read the full interaction report
SeverityMinor
LikelihoodPossible
Interactions2
EvidenceD
What do Severity, Likelihood & Evidence mean?
Know someone taking this? Share
Interaction report

Fucus Vesiculosus and Erdafitinib

These two interact in 2 distinct ways. Each one is explained separately below.

Why Are There 2 Interactions?

Fucus Vesiculosus interacts with whole categories of medication. Erdafitinib falls into 2 of those categories, so it can interact with Fucus Vesiculosus in 2 different ways. We’ve listed each one below — your overall risk is driven by the most serious of them (Minor).

Minor

CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES

1 of 2

Why this applies to Erdafitinib

Erdafitinib falls under CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES — the group Fucus Vesiculosus interacts with.

Theoretically, concomitant use of Fucus vesiculosus with CYP2C9 substrates might increase the risk for adverse effects.
In vitro research shows that fucoidan, a constituent of Fucus vesiculosus, inhibits CYP2C9. This interaction has not been reported in humans.
Severity Minor Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the basic idea with bladderwrack and erdafitinib (Balversa). Your body partly uses a liver enzyme called CYP2C9 to clear erdafitinib. In lab tests (test tube, not real people), a compound in bladderwrack called fucoidan appears to slow that enzyme down. If that happened in your body, erdafitinib could build up a bit more than expected, which in theory might nudge up its side effects like dry mouth, mouth sores, dry or watery eyes, changes in your nails or skin, diarrhea, or shifts in your phosphate levels.

I want to be honest though: this is theoretical, has never been shown in humans, and is rated minor. Since erdafitinib is a serious cancer drug, please just run any bladderwrack use past your oncologist or pharmacist first.

References
  1. Mathew L, Burney M, Gaikwad A, et al. Preclinical evaluation of safety of fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus for use in cancer treatment. Integr Cancer Ther 2017;16(4):572-84.
Minor

CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES

2 of 2

Erdafitinib also falls under CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES.

Theoretically, concomitant use of Fucus vesiculosus with CYP3A4 substrates might increase the risk for adverse effects.
In vitro research shows that fucoidan, a constituent of Fucus vesiculosus, inhibits CYP3A4. This interaction has not been reported in humans.
Severity Minor Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the basic idea with bladderwrack and erdafitinib (Balversa). Your liver uses an enzyme called CYP3A4 to help clear erdafitinib from your body. A compound in bladderwrack called fucoidan has been shown, in lab studies only, to slow that same enzyme down. If that happened in a real person, erdafitinib could build up a little and you might notice more of its usual side effects, like mouth sores, dry eyes or vision changes, high phosphate levels, dry mouth, or diarrhea.

I want to be honest about how soft this is. It's a theoretical, test-tube finding that has never been reported in actual patients, and it's rated as minor. Still, since erdafitinib is a serious cancer drug, please run any bladderwrack use past your oncologist or pharmacist first.

References
  1. Mathew L, Burney M, Gaikwad A, et al. Preclinical evaluation of safety of fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus for use in cancer treatment. Integr Cancer Ther 2017;16(4):572-84.

What These Ratings Mean

Every interaction above is graded three ways — here’s the key to each label.

Severity how clinically significant the interaction is
Major

Clinically significant. Avoid the combination, or use only under close professional supervision.

Moderate

Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.

Minor

Generally not serious. Be aware of it and mention it to your pharmacist.

Likelihood how strong the evidence is that the interaction actually happens in people
  • LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
  • ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
  • UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Evidence the quality of the studies behind the rating (graded A–D)
  • AHigh-quality meta-analysis (quantitative systematic review).
  • BCase-control study.
  • CConsensus.
  • DAnecdotal evidence.

These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.

Keep it in perspective

Fucus Vesiculosus Also Interacts With Other Medications

Fucus Vesiculosus has 23 moderate, 867 minor known drug interactions in our database — the Erdafitinib one above is among them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Fucus Vesiculosus

Covers the 2,830 medications we’ve checked against Fucus Vesiculosus. Pick one to open its full report.

Everything else you take

See Every Supplement That Interacts With Erdafitinib

This page covers Fucus Vesiculosus only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Erdafitinib page lists 169 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), Phosphate Salts (major), St. John's Wort (major) and Acacia Rigidula (moderate).

By severity: 4 major · 127 moderate · 38 minor.

From our pharmacist’s overview on the Erdafitinib page

“Erdafitinib (Balversa) treats bladder cancers driven by FGFR gene changes, and its benefit depends on holding a steady drug level, so this is a list to be genuinely careful with. Four entries are rated major.”

Reviewed by 2 · Jul 18, 2026

Open the Erdafitinib interaction page

How much people look this up

Where Fucus Vesiculosus and Erdafitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Fucus Vesiculosus
Steady interest

#1,036 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Erdafitinib
Steady interest

#1,897 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Supplement

About Fucus Vesiculosus

What is Fucus Vesiculosus?

Fucus Vesiculosus
  • Thyroid support
  • Iodine source
  • Weight management
  • Joint and skin care (topical)
  • Constipation and digestive support

Fucus vesiculosus (bladderwrack) is a brown seaweed rich in iodine that has been used traditionally for thyroid concerns, weight, and skin. There is little solid human evidence to support most of these uses, and its high and variable iodine content can actually harm the thyroid. Talk to a pharmacist or doctor before using it, especially if you have a thyroid condition.

Read the full Fucus Vesiculosus monograph & all interactions
Medication

About Erdafitinib

What Is Erdafitinib Used For?

Brand name: Balversa

Balversa (erdafitinib) is used to treat adults with locally advanced or metastatic urothelial carcinoma (UC) — cancer of the bladder or urinary tract — that has spread and has not responded to, or has gotten worse after, at least one prior round of systemic treatment. Patients must have a specific type of FGFR3 genetic alteration in their tumor, confirmed by an FDA-approved test before starting.

Balversa is not recommended for patients who are eligible for — but have not yet received — a PD-1 or PD-L1 inhibitor (a type of immunotherapy). Those therapies should be tried first when appropriate.

See full Erdafitinib drug information
Keep checking

Other Drugs & Fucus Vesiculosus

Browse every other medication we’ve checked against Fucus Vesiculosus — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
23Moderate
867Minor
1,939No known interaction
Moderate

23 interactions

Minor

867 interactions

Showing 60 of 867 minor interactions — see all 867 on the Fucus Vesiculosus page.

No interaction 1,939 drugs checked — show the list
Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Pharmacist Counseling Corner

Taking Fucus Vesiculosus and Erdafitinib Together: Common Questions

Can you take Fucus Vesiculosus with Erdafitinib?
There is only a minor interaction, which is usually not serious. Read the full details on this page and confirm with your pharmacist before combining them.
Why are there 2 interactions listed for Fucus Vesiculosus and Erdafitinib?
Erdafitinib belongs to more than one drug category, and Fucus Vesiculosus interacts with each of those categories a little differently. We list every one so nothing is missed — your overall risk is driven by the most serious of them.
How serious is the Fucus Vesiculosus and Erdafitinib interaction?
We rate it Minor. This interaction is generally not clinically significant, but it remains worth noting and discussing with your pharmacist.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Erdafitinib and Fucus Vesiculosus?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.